Historical Data Analysis of Hematological Remission and Survival in Adults With R/R Acute Lymphoblastic Leukemia

Completed

Conditions studied: Acute Lymphoblastic Leukemia

In brief

A retrospective analysis of historical data looking at hematological remission and survival in adult relapsed / refractory B-precursor acute lymphoblastic leukemia patients.

Key facts

Study ID

NCT02003612

Run by

Amgen

People needed

2373

Starts

2013-10-01

Expected to finish

2014-04-28

Last updated by the study team

2022-11-07

Who can join

Age: 15 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• adult patients with relapsed / refractory B-precursor acute lymphoblastic leukemia
• age 15 or older at time of de novo (initial) diagnosis of acute lymphoblastic leukemia
• initial diagnosis of acute lymphoblastic leukemia in the year 1990 or later
• No CNS involvement at relapse
• No isolated extramedullary relapse
• Other inclusion criteria may apply

Where it is running

• Research Site — Boston, Massachusetts, United States
• Research Site — Cleveland, Ohio, United States
• Research Site — Brno, Czechia
• Research Site — Paris, France
• Research Site — Frankfurt am Main, Germany
• Research Site — Bologna, Italy
• Research Site — Venezia, Italy
• Research Site — Gliwice, Poland
• Research Site — Badalona, Catalonia, Spain
• Research Site — London, United Kingdom

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.